These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 19436992

  • 1. Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus.
    Kawashima Y, Chen J, Sun H, Lann D, Hajjar RJ, Yakar S, Leroith D.
    Diabetologia; 2009 Jul; 52(7):1434-41. PubMed ID: 19436992
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MKR mice have increased dynamic glucose disposal despite metabolic inflexibility, and hepatic and peripheral insulin insensitivity.
    Vaitheesvaran B, LeRoith D, Kurland IJ.
    Diabetologia; 2010 Oct; 53(10):2224-32. PubMed ID: 20577711
    [Abstract] [Full Text] [Related]

  • 5. Defective lipid delivery modulates glucose tolerance and metabolic response to diet in apolipoprotein E-deficient mice.
    Hofmann SM, Perez-Tilve D, Greer TM, Coburn BA, Grant E, Basford JE, Tschöp MH, Hui DY.
    Diabetes; 2008 Jan; 57(1):5-12. PubMed ID: 17914034
    [Abstract] [Full Text] [Related]

  • 6. Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes.
    Asghar Z, Yau D, Chan F, Leroith D, Chan CB, Wheeler MB.
    Diabetologia; 2006 Jan; 49(1):90-9. PubMed ID: 16362284
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice.
    Mosa R, Huang L, Wu Y, Fung C, Mallawakankanamalage O, LeRoith D, Chen C.
    Endocrinology; 2017 Oct 01; 158(10):3174-3187. PubMed ID: 28977588
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.
    Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, Linton MF, Hotamisligil GS.
    Circulation; 2004 Sep 14; 110(11):1492-8. PubMed ID: 15353487
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus.
    Pennisi P, Gavrilova O, Setser-Portas J, Jou W, Santopietro S, Clemmons D, Yakar S, LeRoith D.
    Endocrinology; 2006 Jun 14; 147(6):2619-30. PubMed ID: 16513827
    [Abstract] [Full Text] [Related]

  • 14. The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE -/- mice fed a western diet.
    Han JH, Oh TJ, Lee G, Maeng HJ, Lee DH, Kim KM, Choi SH, Jang HC, Lee HS, Park KS, Kim YB, Lim S.
    Diabetologia; 2017 Feb 14; 60(2):364-376. PubMed ID: 27866224
    [Abstract] [Full Text] [Related]

  • 15. A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice.
    Fujii A, Allen TJ, Nestel PJ.
    Atherosclerosis; 2007 Jul 14; 193(1):55-61. PubMed ID: 16996521
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes.
    List EO, Palmer AJ, Berryman DE, Bower B, Kelder B, Kopchick JJ.
    Diabetologia; 2009 Aug 14; 52(8):1647-55. PubMed ID: 19468705
    [Abstract] [Full Text] [Related]

  • 17. Involvement of apolipoprotein E in excess fat accumulation and insulin resistance.
    Gao J, Katagiri H, Ishigaki Y, Yamada T, Ogihara T, Imai J, Uno K, Hasegawa Y, Kanzaki M, Yamamoto TT, Ishibashi S, Oka Y.
    Diabetes; 2007 Jan 14; 56(1):24-33. PubMed ID: 17192461
    [Abstract] [Full Text] [Related]

  • 18. Fat distribution, lipid accumulation in the liver, and exercise capacity do not explain the insulin resistance in healthy males with a family history for type 2 diabetes.
    Johanson EH, Jansson PA, Lönn L, Matsuzawa Y, Funahashi T, Taskinen MR, Smith U, Axelsen M.
    J Clin Endocrinol Metab; 2003 Sep 14; 88(9):4232-8. PubMed ID: 12970292
    [Abstract] [Full Text] [Related]

  • 19. Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation.
    Huang ZH, Reardon CA, Getz GS, Maeda N, Mazzone T.
    J Lipid Res; 2015 Feb 14; 56(2):215-26. PubMed ID: 25421060
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
    Mustad VA, Demichele S, Huang YS, Mika A, Lubbers N, Berthiaume N, Polakowski J, Zinker B.
    Metabolism; 2006 Oct 14; 55(10):1365-74. PubMed ID: 16979408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.